Marchex Inc. Files 8-K/A Amendment

TL;DR

Marchex filed an amendment to its 8-K, likely clarifying financial details. Keep an eye on updates.

AI Summary

Marchex, Inc. filed an amendment (8-K/A) on May 8, 2024, to its previous report dated May 7, 2024. This amendment pertains to the company's results of operations and financial condition, as well as its financial statements and exhibits. The filing does not introduce new financial figures but serves to amend or supplement previously disclosed information.

Why It Matters

This filing indicates Marchex, Inc. is providing updated or corrected information regarding its financial performance and condition, which could be material for investors assessing the company's health.

Risk Assessment

Risk Level: medium — Amendments to SEC filings can indicate previously reported information was inaccurate or incomplete, requiring investor attention.

Key Players & Entities

• Marchex, Inc. (company) — Registrant
• May 7, 2024 (date) — Date of earliest event reported
• May 8, 2024 (date) — Date of report and amendment
• Seattle, Washington (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — tered Class B Common Stock, par value $0.01 per share MCHX The Nasdaq Global Se

Filing Documents

• mchx-20240507.htm (8-K/A) — 46KB
• mchx-ex99_1.htm (EX-99.1) — 240KB
• 0000950170-24-055239.txt ( ) — 426KB
• mchx-20240507.xsd (EX-101.SCH) — 31KB
• mchx-20240507_htm.xml (XML) — 6KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On May 7, 2024, Marchex, Inc. (" Marchex ") is issuing a press release and holding a conference call regarding its financial results for the first quarter ended March 31, 2024 (the " Press Release "). The full text of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Marchex is referencing non-GAAP financial information in both the Press Release and on the conference call. A reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures is contained in the attached Press Release. Disclosures regarding definitions of these financial measures used by Marchex and why Marchex's management believes these financial measures provide useful information to investors is also included in the Press Release.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Marchex, dated May 7, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. MARCHEX, INC. Date: May 8, 2024 By: /s/ HOLLY A. AGLIO Name: Holly A. Aglio Title: Chief Financial Officer (Principal Financial Officer)